These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 9597160)
1. Mechanisms of action of bisphosphonates. Rodan GA Annu Rev Pharmacol Toxicol; 1998; 38():375-88. PubMed ID: 9597160 [TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates: the first 40 years. Russell RG Bone; 2011 Jul; 49(1):2-19. PubMed ID: 21555003 [TBL] [Abstract][Full Text] [Related]
3. Nitrogen-containing bisphosphonate mechanism of action. Reszka AA; Rodan GA Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639 [TBL] [Abstract][Full Text] [Related]
4. Physiology of the aging bone and mechanisms of action of bisphosphonates. Dominguez LJ; Di Bella G; Belvedere M; Barbagallo M Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491 [TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Russell RG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH Ann N Y Acad Sci; 2007 Nov; 1117():209-57. PubMed ID: 18056045 [TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates and primary hyperparathyroidism. Rodan GA J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793 [TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates: from the laboratory to the clinic and back again. Russell RG; Rogers MJ Bone; 1999 Jul; 25(1):97-106. PubMed ID: 10423031 [TBL] [Abstract][Full Text] [Related]
8. [Development of bisphosphonates]. Nakatsuka K Nihon Rinsho; 2003 Feb; 61(2):219-25. PubMed ID: 12638211 [TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates: from bench to bedside. Russell RG Ann N Y Acad Sci; 2006 Apr; 1068():367-401. PubMed ID: 16831938 [TBL] [Abstract][Full Text] [Related]
10. [Bisphosphonates: the molecular targets and mechanisms of action]. Wada S; Kamiya S; Ono K Clin Calcium; 2005 May; 15(5):819-24. PubMed ID: 15876745 [TBL] [Abstract][Full Text] [Related]
11. Cellular and molecular mechanisms of action of bisphosphonates. Rogers MJ; Gordon S; Benford HL; Coxon FP; Luckman SP; Monkkonen J; Frith JC Cancer; 2000 Jun; 88(12 Suppl):2961-78. PubMed ID: 10898340 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates in the treatment of metabolic bone diseases. Rodan GA; Balena R Ann Med; 1993 Aug; 25(4):373-8. PubMed ID: 8217103 [TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy. Li B; Ling Chau JF; Wang X; Leong WF J Cell Biochem; 2011 May; 112(5):1229-42. PubMed ID: 21465521 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of the bisphosphonates. Fleisch H Medicina (B Aires); 1997; 57 Suppl 1():65-75. PubMed ID: 9567358 [TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates: how do they work? Papapoulos SE Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):831-47. PubMed ID: 19028359 [TBL] [Abstract][Full Text] [Related]
17. Clinical trials with bisphosphonates. Lombardi A; Santora AC Ann Ital Med Int; 1992; 7(3 Suppl):158S-165S. PubMed ID: 1297394 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in understanding the mechanism of action of bisphosphonates. Coxon FP; Thompson K; Rogers MJ Curr Opin Pharmacol; 2006 Jun; 6(3):307-12. PubMed ID: 16650801 [TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. Hughes DE; Wright KR; Uy HL; Sasaki A; Yoneda T; Roodman GD; Mundy GR; Boyce BF J Bone Miner Res; 1995 Oct; 10(10):1478-87. PubMed ID: 8686503 [TBL] [Abstract][Full Text] [Related]
20. The pharmacology and therapeutic utility of bisphosphonates. Lourwood DL Pharmacotherapy; 1998; 18(4):779-89. PubMed ID: 9692651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]